Literature DB >> 18401714

Endoscopic evaluation in gastrointestinal graft-versus-host disease: comparisons with histological findings.

Dae Young Cheung1, Jin Il Kim, Soon Sub Kim, Hye Young Sung, Se-Hyun Cho, Soo-Heon Park, Joon-Yeol Han, Jae Kwang Kim, Jong-Wook Lee, Woo-Sung Min, Gyeong-Sin Park, Chang Suk Kang.   

Abstract

The gastrointestinal (GI) tract is the major target site of the graft-versus-host disease (GVHD). Whether endoscopic findings can predict the histological diagnosis and degree of severity in GVHD remains controversial. We investigated the degree of correlation between endoscopic and histological findings, and evaluated the impact of endoscopic examination on clinical decision in GVHD management. This study was conducted as a retrospective single-center study. One hundred and one patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and at the risk of GI GVHD were referred for endoscopic evaluation. Endoscopic images and histology were reviewed to diagnose and grade in a blind fashion, and the histological findings were used as the "gold standard" for diagnosis. Endoscopic findings revealed a significantly positive association with histological abnormalities of GVHD (odds ratio [OR] = 33.6, 95% CI 4.3-261.1), and the sensitivity and specificity were 98 and 44%, respectively. The kappa coefficient for agreement between the endoscopic and histological grading was 0.423 (p-value < 0.001). Ten (18%) patients out of 57 histology-negative cases were managed successfully as GVHD on the endoscopic finding. Though the overall reliability of endoscopic diagnosis in GVHD is still insufficient in terms of sensitivity and specificity, high-grade cases such as grades 3 or 4 showed specific endoscopic findings to draw a significant agreement with histological findings. Endoscopic examination can give critical information and impose a pivotal impact on clinical decision when the histology is discordant with clinical presentation.

Entities:  

Mesh:

Year:  2008        PMID: 18401714     DOI: 10.1007/s10620-008-0262-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  16 in total

1.  Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation.

Authors:  R J Ponec; R C Hackman; G B McDonald
Journal:  Gastrointest Endosc       Date:  1999-05       Impact factor: 9.427

Review 2.  Pathogenesis and pathology of graft-vs.-host disease.

Authors:  J E Wagner; G B Vogelsang; W E Beschorner
Journal:  Am J Pediatr Hematol Oncol       Date:  1989

3.  The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.

Authors:  J P Terdiman; C A Linker; C A Ries; L E Damon; H S Rugo; J W Ostroff
Journal:  Endoscopy       Date:  1996-10       Impact factor: 10.093

Review 4.  Intestinal and hepatic complications of human bone marrow transplantation. Part I.

Authors:  G B McDonald; H M Shulman; K M Sullivan; G D Spencer
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

Review 5.  Bone marrow transplantation.

Authors:  J O Armitage
Journal:  N Engl J Med       Date:  1994-03-24       Impact factor: 91.245

6.  Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?

Authors:  Andreas Nydegger; Anthony Graeme Catto-Smith; Karin Tiedemann; Winita Hardikar
Journal:  Pediatr Blood Cancer       Date:  2007-05       Impact factor: 3.167

7.  Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients.

Authors:  D Wu; D M Hockenberry; T A Brentnall; P H Baehr; R J Ponec; R Kuver; S P Tzung; J L Todaro; G B McDonald
Journal:  Transplantation       Date:  1998-11-27       Impact factor: 4.939

8.  Etiology and outcome of diarrhea after marrow transplantation: a prospective study.

Authors:  G J Cox; S M Matsui; R S Lo; M Hinds; R A Bowden; R C Hackman; W G Meyer; M Mori; P I Tarr; L S Oshiro
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

9.  A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation.

Authors:  D C Snover; S A Weisdorf; G M Vercellotti; B Rank; S Hutton; P McGlave
Journal:  Hum Pathol       Date:  1985-04       Impact factor: 3.466

10.  Bone marrow transplant-associated thrombotic microangiopathy: a case series.

Authors:  Z R Zeigler; R K Shadduck; J Nemunaitis; D F Andrews; C S Rosenfeld
Journal:  Bone Marrow Transplant       Date:  1995-02       Impact factor: 5.483

View more
  5 in total

1.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 2.  Fulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature review.

Authors:  Hidetaka Okubo; Naoyoshi Nagata; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

3.  MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease.

Authors:  J-Y Lim; Y-K Lee; S-E Lee; J-M Ju; K-S Eom; Y-J Kim; N-G Chung; D C Jeong; G Park; E Y Choi; C-K Min
Journal:  Mucosal Immunol       Date:  2015-10-07       Impact factor: 7.313

4.  Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.

Authors:  W Kreisel; M Dahlberg; H Bertz; J Harder; K Potthoff; P Deibert; A Schmitt-Graeff; J Finke
Journal:  Bone Marrow Transplant       Date:  2011-06-27       Impact factor: 5.483

5.  Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation.

Authors:  Sae Ohwada; Tomoya Iida; Daisuke Hirayama; Gota Sudo; Toshiyuki Kubo; Masanori Nojima; Kentaro Yamashita; Hiroo Yamano; Hiroshi Nakase
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.